Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Dysmorphic Features
Total 0 results
Nothing found
Sponsors and Collaborators
Enrique Ordiñaga-Monreal, OD, MSc
AdhereTech
Alaska Department of Health and Social Services
Ataturk University SCIENTIFIC RESEARCH PROJECTS COORDINATION UNIT
University Grants Committee, Hong Kong
Huan Wang, MD
Centro Hospitalar de Lisboa Central EPE, Lisboa, Portugal
The Third People's Hospital of Hubei Province
Academia Sinica, Taiwan
Ministry of Science and Technology of the People´s Republic of China
Eva Klappe
WuHui
Etwal Ltd.
Minnesota Medical Development, Inc.
Klinik Bad Oexen, Germany
Maryland Treatment Centers @ ARTC
Olynka Vega Vega
William Xu, MD
NYC RING, Director
The Danish Midwifery Organization
View Full List
Medical Conditions
Chronic Hepatitis C Genotype 1B
Cervical Spine Sprain
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
Primary Intestinal Lymphangiectasia
Orthodontics, Corrective, Palatal Expansion Technique
Food IgE-mediated Allergy
Piperacillin, Tazobactam Drug Combination
Advanced Intestinal Cancer
Human Mammary Carcinoma
Venetoclax Combined With Azacitidine
Gastric Submucosal Tumors
Infertilities
Optim Lead Insulation Related Adverse Events
Urinary Incontinence in Geriatric Population
Post-nasal Drip
Recurrent Pleural Effusions
Primary Hypomagnesemia (Disorder)
Musculoskeletal Injury
Aneurysmal Subarachnoid Hemorrhage, Familial
Accidental Injuries
View Full List
Drug Interventions
Ivermectin
Vitamin D
Viread 300Mg Tablet
Niacin
Peg-Interferon alpha-2b
SOF/VEL
DP001
Experimental drug: ESK-001
Neem plus propylene glycol plus salicylic acid
YYC301-1 & YYC301-2 & YYC301-3
SD-101
Extremecare
ASP8825
Urokinase
Cyclosporine 0.010%
Bempedoic Acid 180 MG Oral Tablet
Peginterferon alfa-2a
PHA-022121 selected dose
2B3-101 50 mg/m2 every 3 weeks
Docetaxel Injection
View Full List
CROs by country
Contract Research Organizations in Bangladesh
Contract Research Organizations in Cyprus
Contract Research Organizations in Denmark
Contract Research Organizations in Egypt
Contract Research Organizations in Finland
Contract Research Organizations in Guinea
Contract Research Organizations in Hungary
Contract Research Organizations in Japan
Contract Research Organizations in Kyrgyzstan
Contract Research Organizations in Mauritius
Contract Research Organizations in Norway
Contract Research Organizations in Serbia
Contract Research Organizations in Ukraine
CRO list by country
CROs in Cameroon
SGS
All CROs in Cameroon
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe